Best Lutetium-177 therapy doctors in Israel: TOP 9 doctors

Prof. Merimsky leads the Unit for Orthopedic Oncology at Sourasky Medical Center, specializing in advanced therapies like Lutetium-177.

• Over 41 years of experience of experience in oncology and sarcoma treatment
• ESMO Faculty member for soft tissue and bone sarcoma
• Fellowship-trained at Institut Gustave Roussy in Paris
• Published extensively on bone and soft tissue malignancies

2,200 rhinoplasties over 17 years – Dr. Yılmaz works exclusively on noses at Memorial Hospital in Istanbul.

• Trained in facial plastic surgery
• Handles both primary procedures and complex revisions
• Member of the European Academy of Facial Plastic Surgery

Leading expert in Lutetium-177 therapy – Dr. Raphael integrates cutting-edge genomic profiling with targeted radionuclide treatments at Sourasky Medical Center.

• Senior lecturer and PI for multiple clinical trials in oncology
• Specializes in thoracic malignancies and advanced phase clinical trials
• Member of ESMO and IASLC, focusing on innovative treatments
• Leader of the Israeli National Genomic Medicine Initiative in oncology
• Outstanding teacher at Tel-Aviv University Faculty of Medicine

Director of oncology hospitalization at Sourasky Medical Center – Dr. Stepfansky specializes in advanced treatment protocols.

• 26 years of experience of experience in oncology, including research roles
• Primary and secondary researcher for phase 1-3 clinical studies
• Specializes in internal medicine and oncology
• Practiced at leading medical centers in Belarus and Israel

Dr. Inna Ospovat leads the nuclear therapy department at Ichilov Clinic, specializing in Lutetium-177 PRRT – a breakthrough for neuroendocrine tumors.

• Specializes in radiation therapy for gastrointestinal and lung cancers
• Trained in oncology and radiation therapy at Hadassah University Hospital
• Member of ASTRO and ISCORT
• Fellowship at PMH University Hospital in Toronto

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Rifaat Safadi leads the liver disease unit at Hadassah Medical Center, specializing in advanced treatments like Lutetium-177 therapy.

• Over 38 years of experience of experience in gastroenterology and hepatology
• Fellowship-trained at Sinai School of Medicine in New York
• Member of international liver study associations
• Author of numerous articles in hepatology
• Recipient of multiple scientific awards for liver research